Want to see SE:SLEEP full AI Analyst Report?
Top Page
Sleep Cycle AB
(SLEEP)
Select Model
Select Model
Rating:62Neutral
Price Target:
kr22.50
▼(-10.00% Downside)
Action:Downgraded
Date:08/27/26
The score is primarily supported by a conservatively financed balance sheet and historically strong profitability, but is held back by deteriorating TTM fundamentals (revenue, margins, and especially free cash flow) and mixed-to-weak near-term technical momentum. Valuation is reasonable with a moderate P/E and a modest dividend yield.
Positive Factors
Low leverage
Conservative financing limits balance-sheet risk and preserves flexibility to fund operations, product development, or shareholder returns. Low debt also reduces exposure to interest costs and refinancing pressure, supporting resilience over the next several quarters.
Negative Factors
Revenue contraction
The recent revenue decline weakens the company’s growth profile and makes future earnings less predictable. Continued contraction could limit operating leverage, reduce resources for product investment, and challenge the ability of the subscription base to expand or retain spending.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Conservative financing limits balance-sheet risk and preserves flexibility to fund operations, product development, or shareholder returns. Low debt also reduces exposure to interest costs and refinancing pressure, supporting resilience over the next several quarters.
Read all positive factors
Sleep Cycle AB (SLEEP) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr466.38M
Dividend Yield2.3%
Average Volume (3M)4.32K
Price to Earnings (P/E)19.0
Beta (1Y)0.10
Revenue Growth-15.03%
EPS Growth-60.80%
CountrySE
Employees39
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)1.21
Shares Outstanding20,277,563
10 Day Avg. Volume4,395
30 Day Avg. Volume4,318
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)7.24
Price to Sales (P/S)2.10
P/FCF Ratio9.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.88
Revenue Forecast (FY)kr209.00M
Sleep Cycle AB Business Overview & Revenue Model
Company Description
Founded in 2001 and headquartered in Gothenburg, Sweden, Sleep Cycle AB (publ) specializes in providing applications for sleep monitoring. The company also engineers various devices designed to track both sleep and general health. Its flagship off...
How the Company Makes Money
Sleep Cycle AB primarily makes money through subscription revenue generated by its Sleep Cycle app. The company offers premium/paid plans that unlock advanced features (e.g., expanded analytics and insights, additional functionality and content), ...
Sleep Cycle AB Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 224.92M | 247.88M | 261.53M | 236.15M | 213.27M | 182.94M |
| Gross Profit | 52.96M | 121.36M | 201.87M | 128.55M | 156.65M | 141.62M |
| EBITDA | 37.20M | 73.62M | 88.45M | 64.05M | 46.27M | 12.37M |
| Net Income | 24.48M | 53.21M | 62.64M | 46.14M | 33.94M | 8.11M |
Balance Sheet | ||||||
| Total Assets | 194.46M | 200.15M | 236.49M | 230.54M | 301.37M | 227.76M |
| Cash, Cash Equivalents and Short-Term Investments | 99.09M | 120.85M | 144.82M | 133.47M | 232.86M | 165.51M |
| Total Debt | 5.81M | 7.38M | 11.74M | 15.92M | 4.20M | 2.49M |
| Total Liabilities | 133.83M | 128.31M | 157.04M | 169.55M | 140.54M | 118.86M |
| Stockholders Equity | 60.63M | 71.83M | 79.46M | 61.00M | 160.83M | 108.90M |
Cash Flow | ||||||
| Free Cash Flow | 11.46M | 52.88M | 59.73M | 51.00M | 53.76M | 14.15M |
| Operating Cash Flow | 31.08M | 52.93M | 63.66M | 52.72M | 61.53M | 20.09M |
| Investing Cash Flow | -30.60M | -13.15M | -3.92M | -6.81M | -7.77M | -5.93M |
| Financing Cash Flow | -13.85M | -64.19M | -48.36M | -145.30M | 14.01M | 98.22M |
Sleep Cycle AB Technical Analysis
Positive
25.00
Price Trends
23.81
Negative
23.55
Negative
21.55
Positive
Market Momentum
-0.47
Negative
50.58
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SLEEP, the sentiment is Positive. The current price of 25 is above the 20-day moving average (MA) of 22.63, above the 50-day MA of 23.81, and above the 200-day MA of 21.55, indicating a neutral trend. The MACD of -0.47 indicates Negative momentum. The RSI at 50.58 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SLEEP.
Sleep Cycle AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | kr7.36B | 29.06 | 21.22% | 1.27% | -15.19% | -47.39% | |
62 Neutral | kr466.38M | 19.01 | 36.23% | 2.30% | -15.03% | -60.80% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
44 Neutral | kr170.29M | -7.81 | ― | ― | -47.90% | 36.77% | |
44 Neutral | kr2.07B | -15.51 | ― | ― | 35.21% | 40.30% | |
41 Neutral | kr146.46M | -1.53 | ― | ― | -19.34% | -1.24% |
* Technology Sector Average
SE:SLEEP
Sleep Cycle AB
23.00
-1.69
-6.86%
SE:CFISH
Crunchfish AB
2.06
-1.92
-48.37%
SE:TRUE.B
Truecaller AB Class B
22.01
-21.87
-49.84%
SE:SEYE
Smart Eye AB
52.90
-32.80
-38.27%
SE:BUSER
Bambuser AB
18.20
-5.56
-23.40%
Sleep Cycle AB Corporate Events
Sleep Cycle to Restructure Organisation for AI-Driven Efficiency and SEK 35 Million in Annual Savings
Sep 17, 2026
Sleep Cycle plans to streamline its organisation and adopt a more AI-driven way of working, reducing management layers and forming smaller decision-making teams led by experienced leaders. Around 15 positions will be affected and several consultan...
Sleep Cycle’s Sleep Data Powers Global Study Linking Air Pollution to Nighttime Coughing
Sep 15, 2026
Sleep Cycle’s AI-driven sound technology has been used in a peer-reviewed study led by the University of Cambridge and Tsinghua University to explore links between air pollution and nighttime coughing in 32 cities across 12 countries. The ap...
Sleep Cycle Fast-Tracks European Launch of AI Sleep Apnea Tool
Sep 11, 2026
Sleep Cycle AB, a leading sleep technology firm based in Gothenburg, is expanding beyond its roots as a consumer sleep app into a regulated medical platform. The company is focusing on AI-based sleep apnea risk detection, aiming to serve consumers...
Sleep Cycle Tech Built Into Moera Smart Mattress Toppers
Sep 4, 2026
Sleep Cycle has deepened its push into licensed sleep technology as partner Moera unveils temperature‑regulating mattress toppers powered by the Swedish company’s patented AI sound model. The new connected‑bedroom products embed ...
Sleep Cycle Study Shows App Cough Data Can Flag Flu and COVID‑19 a Week Early
Sep 3, 2026
Sleep Cycle has released findings from a three‑year research collaboration with the UK Health Security Agency showing that anonymized nocturnal cough data from its app can act as an early indicator of community respiratory illness. By compar...
Sleep Cycle names tech chief Mikael Kågebäck acting CEO amid strategic review
Aug 27, 2026
Sleep Cycle AB has named Chief Technology and Product Officer Mikael Kågebäck as acting chief executive officer, effective 27 August 2026, following the departure of CEO Erik Jivmark. The leadership change comes shortly after Altor, via ...
Sleep Cycle’s Earnings Slide as Altor-Backed BidCo Takes Control and B2B Deals Grow
Aug 26, 2026
Sleep Cycle reported a sharp revenue decline and margin compression in the second quarter of 2026, with net sales down 21.5% and EBITDA turning negative amid falling subscriber numbers and costs related to extraordinary items. Despite weaker consu...
Sleep Cycle to Webcast Second-Quarter 2026 Interim Report
Aug 24, 2026
Sleep Cycle AB will present its interim report for the second quarter of 2026 on 26 August via a public webcast aimed at shareholders, media and other stakeholders. The presentation, held in English by CEO Erik Jivmark and CFO Head of IR Elisabet...
Sleep Cycle installs new investor-aligned board in governance overhaul
Aug 5, 2026
Sleep Cycle AB has overhauled its governance structure at an Extraordinary General Meeting on 5 August 2026, confirming a five-member board without deputies and setting annual fees of SEK 500,000 for the chair and SEK 250,000 for each other direct...
Sleep Cycle partners with Ant Group to expand AI sleep tech into China
Jul 23, 2026
Sleep Cycle has signed an AI-powered SDK licensing agreement with Ant Group, operator of China’s Alipay platform, to integrate its proprietary audio-based sleep analysis technology into Ant’s digital health services under a one-year pi...
Sleep Cycle Calls EGM as New Majority Owner Reshapes Board and Fees
Jul 10, 2026
Sleep Cycle AB has called an extraordinary general meeting in Stockholm on 5 August 2026, following Snark BidCo AB’s completion of its offer and acquisition of 78.2 percent of the company’s shares and votes. The meeting will handle for...
Sleep Cycle seals Ultrahuman SDK deal to scale ‘Powered by Sleep Cycle’ strategy
Jul 3, 2026
Sleep Cycle has signed a commercial software licensing agreement with global health and wearable technology company Ultrahuman, formalizing and extending a pilot that began in November 2025. The deal allows Ultrahuman to continue integrating Sleep...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.